Growth Metrics

Veracyte (VCYT) Income from Continuing Operations (2016 - 2025)

Veracyte (VCYT) has disclosed Income from Continuing Operations for 14 consecutive years, with 41186000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 701.75% to 41186000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 66372000.0 through Dec 2025, up 174.78% year-over-year, with the annual reading at 66353000.0 for FY2025, 174.89% up from the prior year.
  • Income from Continuing Operations hit 41186000.0 in Q4 2025 for Veracyte, up from 19089000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 41186000.0 in Q4 2025 to a low of 41863000.0 in Q1 2021.
  • Historically, Income from Continuing Operations has averaged 4789600.0 across 5 years, with a median of 8234000.0 in 2023.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 641.71% in 2023 and later soared 701.75% in 2025.
  • Year by year, Income from Continuing Operations stood at 10465000.0 in 2021, then surged by 63.55% to 3814000.0 in 2022, then tumbled by 641.71% to 28289000.0 in 2023, then surged by 118.16% to 5137000.0 in 2024, then skyrocketed by 701.75% to 41186000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for VCYT at 41186000.0 in Q4 2025, 19089000.0 in Q3 2025, and 950000.0 in Q2 2025.